BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18565243)

  • 1. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
    Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
    Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis.
    Pattacini L; Boiardi L; Casali B; Salvarani C
    Rheumatology (Oxford); 2010 Mar; 49(3):480-9. PubMed ID: 20040530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.
    Vomero M; Manganelli V; Barbati C; Colasanti T; Capozzi A; Finucci A; Spinelli FR; Ceccarelli F; Perricone C; Truglia S; Morrone S; Maggio R; Misasi R; Bombardieri M; Di Franco M; Conti F; Sorice M; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jan; 21(1):39. PubMed ID: 30696478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
    Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
    Arthritis Rheum; 2005 Nov; 52(11):3439-47. PubMed ID: 16255020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study.
    Talotta R; Berzi A; Atzeni F; Dell'Acqua D; Sarzi Puttini P; Trabattoni D
    Reumatismo; 2016 Sep; 68(2):83-9. PubMed ID: 27608796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
    Van den Brande JM; Braat H; van den Brink GR; Versteeg HH; Bauer CA; Hoedemaeker I; van Montfrans C; Hommes DW; Peppelenbosch MP; van Deventer SJ
    Gastroenterology; 2003 Jun; 124(7):1774-85. PubMed ID: 12806611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
    Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
    Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 gene expression in patients with rheumatoid arthritis.
    Kohno M; Tsutsumi A; Matsui H; Sugihara M; Suzuki T; Mamura M; Goto D; Matsumoto I; Ito S; Suguro T; Sumida T
    Mod Rheumatol; 2008; 18(1):15-22. PubMed ID: 18092129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
    Meusch U; Rossol M; Baerwald C; Hauschildt S; Wagner U
    Arthritis Rheum; 2009 Sep; 60(9):2612-21. PubMed ID: 19714631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis.
    Baldwin HM; Ito-Ihara T; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Jun; 69(6):1200-7. PubMed ID: 19773288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents.
    Halvorsen EH; Haavardsholm EA; Pollmann S; Boonen A; van der Heijde D; Kvien TK; Molberg Ø
    Ann Rheum Dis; 2009 Feb; 68(2):249-52. PubMed ID: 18723564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.
    Maxwell JR; Potter C; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
    Hum Mol Genet; 2008 Nov; 17(22):3532-8. PubMed ID: 18713756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.